These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 16515457

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade.
    Chiti F, Dobson CM.
    Annu Rev Biochem; 2017 Jun 20; 86():27-68. PubMed ID: 28498720
    [Abstract] [Full Text] [Related]

  • 3. Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains.
    DuBay KF, Pawar AP, Chiti F, Zurdo J, Dobson CM, Vendruscolo M.
    J Mol Biol; 2004 Aug 27; 341(5):1317-26. PubMed ID: 15302561
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Protein Misfolding Diseases.
    Hartl FU.
    Annu Rev Biochem; 2017 Jun 20; 86():21-26. PubMed ID: 28441058
    [Abstract] [Full Text] [Related]

  • 8. Misfolded proteins in Alzheimer's disease and type II diabetes.
    DeToma AS, Salamekh S, Ramamoorthy A, Lim MH.
    Chem Soc Rev; 2012 Jan 21; 41(2):608-21. PubMed ID: 21818468
    [Abstract] [Full Text] [Related]

  • 9. Peptide-Based Molecular Strategies To Interfere with Protein Misfolding, Aggregation, and Cell Degeneration.
    Armiento V, Spanopoulou A, Kapurniotu A.
    Angew Chem Int Ed Engl; 2020 Feb 24; 59(9):3372-3384. PubMed ID: 31529602
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Protein conformational misfolding and amyloid formation: characteristics of a new class of disorders that include Alzheimer's and Prion diseases.
    Thompson AJ, Barrow CJ.
    Curr Med Chem; 2002 Oct 24; 9(19):1751-62. PubMed ID: 12369885
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC.
    Ann N Y Acad Sci; 2005 Dec 24; 1066():181-221. PubMed ID: 16533927
    [Abstract] [Full Text] [Related]

  • 15. A generic mechanism of emergence of amyloid protofilaments from disordered oligomeric aggregates.
    Auer S, Meersman F, Dobson CM, Vendruscolo M.
    PLoS Comput Biol; 2008 Nov 24; 4(11):e1000222. PubMed ID: 19008938
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interpreting the aggregation kinetics of amyloid peptides.
    Pellarin R, Caflisch A.
    J Mol Biol; 2006 Jul 21; 360(4):882-92. PubMed ID: 16797587
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Computational studies of protein aggregation: methods and applications.
    Morriss-Andrews A, Shea JE.
    Annu Rev Phys Chem; 2015 Apr 21; 66():643-66. PubMed ID: 25648485
    [Abstract] [Full Text] [Related]

  • 20. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution.
    Stefani M, Dobson CM.
    J Mol Med (Berl); 2003 Nov 21; 81(11):678-99. PubMed ID: 12942175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.